160 related articles for article (PubMed ID: 38064181)
1. MMP-2 regulates Src activation via repression of the CHK/MATK tumor suppressor in osteosarcoma.
Maybee DV; Cromwell CR; Hubbard BP; Ali MAM
Cancer Rep (Hoboken); 2023 Dec; 7(2):e1946. PubMed ID: 38064181
[TBL] [Abstract][Full Text] [Related]
2. CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
Chüeh AC; Advani G; Foroutan M; Smith J; Ng N; Nandurkar H; Lio DS; Zhu HJ; Chong YP; Verkade H; Fujita DJ; Bjorge J; Basheer F; Lim JP; Luk I; Dhillon A; Sakthianandeswaren A; Mouradov D; Sieber O; Hollande F; Mariadason JM; Cheng HC
Oncogene; 2021 Apr; 40(17):3015-3029. PubMed ID: 33767439
[TBL] [Abstract][Full Text] [Related]
3. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
[TBL] [Abstract][Full Text] [Related]
4. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
[TBL] [Abstract][Full Text] [Related]
5. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
6. The Csk-like proteins Lsk, Hyl, and Matk represent the same Csk homologous kinase (Chk) and are regulated by stem cell factor in the megakaryoblastic cell line MO7e.
Grgurevich S; Linnekin D; Musso T; Zhang X; Modi W; Varesio L; Ruscetti FW; Ortaldo JR; McVicar DW
Growth Factors; 1997; 14(2-3):103-15. PubMed ID: 9255603
[TBL] [Abstract][Full Text] [Related]
7. Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice.
Lee BC; Avraham S; Imamoto A; Avraham HK
Blood; 2006 Aug; 108(3):904-7. PubMed ID: 16574955
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of Csk and CHK kinases in breast cancer cells.
Bougeret C; Jiang S; Keydar I; Avraham H
J Biol Chem; 2001 Sep; 276(36):33711-20. PubMed ID: 11445575
[TBL] [Abstract][Full Text] [Related]
9. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
[TBL] [Abstract][Full Text] [Related]
10. Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells.
Zrihan-Licht S; Lim J; Keydar I; Sliwkowski MX; Groopman JE; Avraham H
J Biol Chem; 1997 Jan; 272(3):1856-63. PubMed ID: 8999872
[TBL] [Abstract][Full Text] [Related]
11. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading.
Hirao A; Huang XL; Suda T; Yamaguchi N
J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346
[TBL] [Abstract][Full Text] [Related]
13. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
[TBL] [Abstract][Full Text] [Related]
14. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
[TBL] [Abstract][Full Text] [Related]
15. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
16. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
[TBL] [Abstract][Full Text] [Related]
17. Regulation, targets and functions of CHK.
Zhu S; Sun R; Guo X; Bao Y; Zhang D
Front Cell Dev Biol; 2022; 10():1068952. PubMed ID: 36568988
[TBL] [Abstract][Full Text] [Related]
18. Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line.
Davidson D; Chow LM; Veillette A
J Biol Chem; 1997 Jan; 272(2):1355-62. PubMed ID: 8995444
[TBL] [Abstract][Full Text] [Related]
19. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
[TBL] [Abstract][Full Text] [Related]
20. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.
Hirao A; Hamaguchi I; Suda T; Yamaguchi N
EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]